Drug Information

General Information
Drug ID
DR00071
Drug Name
Valsartan
Synonyms
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; Aventis brand of valsartan; CEPA brand of valsartan; CGP 48933; CGP-48933; Diovan; Diovan (TN); Diovan, Valsartan; Esteve brand of valsartan; Kalpress; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI); Lacer brand of valsartan; Miten; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Nisis; Novartis brand of valsartan; Provas; Sanol brand of valsartan; Schwarz brand of valsartan; Tareg; Vals; Valsarran; Valsartan (JAN/USAN/INN); Valsartan [USAN:INN]; Valtan (TN); Valzaar (TN); Walsartan
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C24H29N5O3
Canonical SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O
InChI
InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1
InChIKey
ACWBQPMHZXGDFX-QFIPXVFZSA-N
CAS Number
CAS 137862-53-4
Pharmaceutical Properties Molecular Weight 435.5 Topological Polar Surface Area 112
Heavy Atom Count 32 Rotatable Bond Count 10
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
4.4
PubChem CID
60846
PubChem SID
103292815 , 103979540 , 104253413 , 104321799 , 11066615 , 11364700 , 11367262 , 11369824 , 11373100 , 11374217 , 11377988 , 11484996 , 11488936 , 11491646 , 11492564 , 11495610 , 117541337 , 117664453 , 119526522 , 123055291 , 124659015 , 124757534 , 124800101 , 125164338 , 14856825 , 14881173 , 26612829 , 26719825 , 43118184 , 46386599 , 46509000 , 46530915 , 47499543 , 48393917 , 49681716 , 49830875 , 50062253 , 50467452 , 53787275 , 57314146 , 7847466 , 81093312 , 85788951 , 90452226 , 92124805 , 92308052 , 92308462 , 92711441 , 93166503 , 99228303
ChEBI ID
ChEBI:9927
TTD Drug ID
D06UDG
DT(s) Transporting This Drug MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [2]
OAT3 Transporter Info Organic anion transporter 3 Substrate [3]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [4]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [2]
PEPT1 Transporter Info Peptide transporter 1 Substrate [5]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MRP2 Transporter Info Km = 30.4 microM LLC-PK1 cells-MRP2 [2]
OATP1B1 Transporter Info Km = 17.8 microM Chinese hamster ovary (CHO) cells-OATP1B1 [6]
OATP1B1 Transporter Info Km = 1.39 microM Human embryonic kidney cells (HEK293)-OATP1B1 [2]
OATP1B3 Transporter Info Km = 23.5 microM Chinese hamster ovary (CHO) cells-OATP1B3 [6]
OATP1B3 Transporter Info Km = 18.2 microM Human embryonic kidney cells (HEK293)-OATP1B3 [2]
References
1 Valsartan was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans. Drug Metab Dispos. 2006 Jul;34(7):1247-54.
3 Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments. Drug Metab Dispos. 2011 Jun;39(6):1031-8.
4 Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. Int J Mol Sci. 2018 Mar 14;19(3). pii: E855.
5 High-affinity interaction of sartans with H+/peptide transporters. Drug Metab Dispos. 2009 Jan;37(1):143-9.
6 Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data. J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):585-611.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.